Creative Planning’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$454K Sell
18,535
-6,786
-27% -$123K ﹤0.01% 3259
2026
Q1
$443K Buy
+25,321
New +$488K ﹤0.01% 3119

Other funds holding BIOA

Creative Planning's BIOA Position: Q2 2026 in Review

Creative Planning reduced its BioAge Labs (BIOA) stake by 27% in Q2 2026, selling an estimated $123K and leaving 18,535 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #3259.

Creative Planning first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Creative Planning held 18,535 shares of BioAge Labs worth $454K as of Q2 2026.
  • Creative Planning sold 6,786 BioAge Labs shares in Q2 2026, an estimated $123K.
  • BioAge Labs made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3259 holding.
  • Creative Planning first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.